Manage allergy symptoms to improve refractive outcomes
February 15th 2007Las Vegas-Identification and pretreatment of allergy patients can improve refractive surgical outcomes, said Deepinder K. Dhaliwal, MD, at a continuing medical education symposium at the American Academy of Ophthalmology annual meeting. About 20% to 30% of refractive surgery patients have associated allergies, she added.
Contact lens intolerant allergy sufferers find relief
February 15th 2007Wantagh, NY-Results of a multicenter, randomized, open-label study demonstrate that twice-daily epinastine HCl 0.05% ophthalmic solution (Elestat, Inspire Pharmaceuticals and Allergan) has significant value compared with use of rewetting drops only for improving comfort among allergy patients suffering with contact lens intolerance.
Focus on preventing corneal complications
February 15th 2007Las Vegas-Ocular allergies affect up to 40% of the pediatric population, and this high prevalence has ramifications beyond providing symptom relief, said Terry Kim, MD, during a continuing medical education symposium here at the annual meeting of the American Academy of Ophthalmology.
New technology helps in vision assessment of preverbal child
February 15th 2007Las Vegas-Steady-state visual evoked potential (SSVEP) is a promising research tool for vision assessment in the preverbal patient and one that is being used increasingly in the clinic, said William V. Good, MD, who discussed his research here during the annual meeting of the American Academy of Ophthalmology.
Bausch & Lomb, AcuFocus announce alliance for presbyopia-correcting technology
February 7th 2007Rochester, NY-Bausch & Lomb has made an equity investment in-and has secured an exclusive option to purchase-AcuFocus Inc., a privately held company in Irvine, CA, that is developing a corneal inlay (ACI 7000) for the treatment of presbyopia.
Ranibizumab study yields stroke concern
February 7th 2007South San Francisco, CA-An ongoing study of ranibizumab (Lucentis, Genentech) has found a higher incidence of stroke in patients with neovascular (wet) age-related macular degeneration who were administered a 0.5-mg dose intravitreally compared with patients who were given a 0.3-mg dose intravitreally (1.2% versus 0.3%, respectively; p = 0.02).
Multizone LASIK technique considered safe, effective
February 1st 2007Jeddah, Saudi Arabia-Multizone LASIK with peripheral near zone ablation to correct presbyopia together with myopia or hyperopia is safe, effectively corrects spherical error, and improves near vision but without offering a high rate of spectacle independence, according to a study from refractive surgeons here at the Magrabi Hospital.
Alternative strategies successful in managing IFIS
February 1st 2007Las Vegas-Ophthalmologists can use one of several modified strategies to perform cataract surgery in patients who are taking or have taken tamsulosin (Flomax, Boehringer Ingelheim Pharmaceuticals), with good outcomes and low complication rates, when they know of the medication history in advance, David F. Chang, MD, told those attending the annual meeting of the American Academy of Ophthalmology here.
Link between glaucoma, sleep apnea unclear
February 1st 2007Las Vegas-Studies have found conflicting evidence that sleep apnea is a risk factor for glaucoma, with variable control groups and variability in defining sleep apnea and glaucoma contributing to the disagreement. Parag A. Gokhale, MD, speaking here at the annual meeting of the American Academy of Ophthalmology, said he sides with those who believe that a positive association exists between the two conditions.
Canaloplasty safely enhances aqueous outflow
February 1st 2007Sacramento, CA-Dilation of Schlemm's canal to 360? and use of a tension suture result in significantly decreased postoperative IOP levels, said Richard A. Lewis, MD, who is in private practice here. The procedure, canaloplasty, safely enhances aqueous outflow in patients with primary open-angle glaucoma (POAG), said Dr. Lewis, reporting the findings of an ongoing prospective multi-site study being conducted in the United States, the European Union, and South Africa.
Intracameral bevacizumab resolves neovascularization
February 1st 2007Las Vegas-Intracameral injection of the anti-VEGF antibody bevacizumab (Avastin, Genentech) dramatically resolves iris neovascularization and reverses neovascular glaucoma, according to the findings of a retrospective study presented here at the annual meeting of the American Academy of Ophthalmology.
RLE accompanied by ethical considerations
February 1st 2007Las Vegas-Refractive lens exchange (RLE) is associated with an increased burden of informed consent disclosure because of the complex issues, both current and future, accompanying that procedure, said Douglas D. Koch, MD, at the Refractive Sur-gery Subspecialty Day during the American Academy of Ophthalmology annual meeting.
Multizone LASIK technique considered safe, effective
February 1st 2007Jeddah, Saudi Arabia-Multizone LASIK with peripheral near zone ablation to correct presbyopia together with myopia or hyperopia is safe, effectively corrects spherical error, and improves near vision but without offering a high rate of spectacle independence, according to a study from refractive surgeons here at the Magrabi Hospital.
Troutman Award winner's focus is on wavefront findings
February 1st 2007Las Vegas-Marcelo V. Netto, MD, was presented with the 16th annual Troutman Award at the annual meeting of the American Academy of Ophthalmology. He received the award as lead author of a paper that described the findings from wavefront analysis in a population of normal refractive surgery patients [Netto MV, et al. J Refract Surg. 2005;21:332-338].
CK effects, results may be temporary
February 1st 2007Stanford, CA-Refractive surgeons performing conductive keratoplasty (CK, Refractec) for correction of mild to moderate hyperopia can expect good visual results initially, but they should warn patients that CK effects might not be permanent, explained Jason S. Ehrlich, MD, PhD.
Torsional phaco offers improvement over standard phaco
February 1st 2007Santiago, Chile-Torsional phacoemulsification seems to be an improvement over standard phacoemulsification because of lower amounts of turbulence, less repulsion of the nuclear fragments, and a different pattern of cavitation due to a 90? shift in the delivery of the ultrasonic power, according to Jaime Zacharias, MD.
Bimanual microincision phaco has advantages in safety, efficiency versus ultra-small coaxial phaco
February 1st 2007Investigators are eagerly comparing ways to perform phacoemulsification to obtain the best results for patients. Bimanual microincision phaco has been receiving a great deal of attention and is being compared with ultra-small-incision coaxial phaco and with conventional phaco.
Cavitation necessary to produce efficient phaco
February 1st 2007Las Vegas-Laboratory experiments involving an overpressurization technique have demonstrated that acoustic transient cavitation is necessary to produce efficient phacoemulsification, according to Mark E. Schafer, PhD, speaking here at the annual meeting of the American Academy of Ophthalmology (AAO).
Endocapsular tension ring a help in traumatic cataract
February 1st 2007Cincinnati-Use of the Cionni endocapsular tension ring (Morcher, FCI Ophthalmics) in traumatic cataract with zonular dialysis provided improved best-corrected visual acuity (BCVA) in 95% of eyes. In addition, none of the eyes with preoperative phacodonesis or decentration had these complications postoperatively, according to Daniela Marques, MD, MBA.
New phaco technology offers customizable features
February 1st 2007Minneapolis-A new phacoemulsification system (Stellaris Vision Enhancement System, Bausch & Lomb) is state-of-the-art technology designed to meet the current and future needs of the contemporary phaco surgeon and surgical staff, according to Elizabeth A. Davis, MD.
Modifying sterilization may help in TASS
February 1st 2007Las Vegas-Existing sterilization techniques, particularly those used in higher-volume, rapid-turnover operating rooms, may need to be modified to avoid and control future outbreaks of toxic anterior segment syndrome (TASS), Simon P. Holland, MD, FRCSC, said at the annual meeting of the American Academy of Ophthalmology here.
Study tracks incidence, risk factors in floppy iris syndrome
February 1st 2007Charleston, SC-A large study of routine phacoemulsification found the total incidence of intraoperative floppy iris syndrome (IFIS) to be 3.8%. In addition to the use of tamsulosin (Flomax, Boehringer Ingelheim Pharmaceuticals) before surgery, angiotensin antagonists and saw palmetto also were implicated in the development of IFIS.